1. Home
  2. HOUR vs IXHL Comparison

HOUR vs IXHL Comparison

Compare HOUR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

HOLD

Current Price

$1.98

Market Cap

72.5M

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.41

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOUR
IXHL
Founded
2015
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
72.5M
49.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HOUR
IXHL
Price
$1.98
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.1K
24.9M
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$140,790,433.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$83.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.08
52 Week High
$6.90
$2.25

Technical Indicators

Market Signals
Indicator
HOUR
IXHL
Relative Strength Index (RSI) 45.70 52.82
Support Level $1.99 $0.38
Resistance Level $2.11 $0.45
Average True Range (ATR) 0.11 0.04
MACD 0.01 0.00
Stochastic Oscillator 25.71 47.53

Price Performance

Historical Comparison
HOUR
IXHL

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: